Article

Biden Cancer Initiative Announces Oncology Clinical Trial Information Commons

In an effort to allow patients to know their clinical trial options, the Biden Cancer Initiative has announced that 9 healthcare innovators are coming together to form the Oncology Clinical Trial Information Commons.

In an effort to allow patients to know their clinical trial options, the Biden Cancer Initiative has announced that 9 healthcare innovators are coming together to form the Oncology Clinical Trial Information Commons. The shared platform, which will be used to sore information on clinical trials and be accessed for patient matching and other data mining, will employ a single set of terms ad rules and a user-friendly interface for companies to enter and update information, such as patient selection criteria, trial locations, and patient participation requirements.

Founding members of the collaboration include BreastCancerTrials.org, Cancer Commons, Ciitizen, EmergingMed, GenomOncology, Genospace/Sarag Cannon Research Center, IBM Watson Health, Massive Bio, and Syapse.

Read the full release.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Merrill H. Stewart, MD
Nicolas Ferreyros, managing director, Community Oncology Alliance
Dr Ibrahim Aldoss
Mansi Shah, MD
Dr Ibrahim Aldoss
Mansi Shah, MD
Dr John Mascarenhas
Merrill H. Stewart, MD
Dr John Mascarenhas
Dr Sundar Jagannath
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo